IP Library Granted Patent US 7,195,893
Granted Patent B2
US 7,195,893 · App. 10/918,602 · Granted Mar 27, 2007

Nucleic acids encoding α

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,195,893
App. No.
10/918,602
Granted
Mar 27, 2007
Kind
B2
Abstract

A new class of α 2 δ subunits which function in calcium ion channels is described. This class is avian derived.

Claims (26)

1. An isolated or recombinant nucleic acid which comprises a nucleotide sequence that encodes a protein which functions as an α 2 δ calcium ion channel subunit in that when it is associated with an α 1 subunit and optionally a β subunit it enhances the density of current flow in the calcium ion channel thus created, and

which protein has at least 85% sequence identity to the amino acid sequence set forth as SEQ ID NO:2.

2. The isolated or recombinant nucleic acid of claim 1 , wherein said nucleotide sequence encodes a protein having at least 90% sequence identity to the amino acid sequence of SEQ ID NO:2.

3. The isolated or recombinant nucleic acid of claim 1 , wherein said nucleotide sequence encodes a protein having at least 95% sequence identity to the amino acid sequence of SEQ ID NO:2.

4. The isolated or recombinant nucleic acid of claim 1 , wherein said nucleotide sequence encodes a protein having the amino acid sequence of SEQ ID NO:2.

5. The isolated or recombinant nucleic acid of claim 1 , wherein said nucleotide sequence has at least 85% sequence identity to SEQ ID NO:1.

6. The isolated or recombinant nucleic acid of claim 1 , wherein said nucleotide sequence has at least 90% sequence identity to SEQ ID NO:1.

7. The isolated or recombinant nucleic acid of claim 1 , wherein said nucleotide sequence has at least 95% sequence identity to SEQ ID NO:1.

8. The isolated or recombinant nucleic acid of claim 1 , wherein said nucleotide sequence is identical to SEQ ID NO: 1.

9. A recombinant nucleic acid molecule which comprises a nucleotide sequence as set forth in claim 1 , operably linked to heterologous control sequences to effect its expression.

10. The recombinant nucleic acid of claim 9 , wherein said control sequences are operable in at least vertebrate cells.

11. Recombinant host cells comprising the nucleic acid molecule of claim 9 .

12. Vertebrate cells comprising the nucleic acid molecule of claim 10 .

13. A method to produce a recombinant protein that exhibits α 2 δ calcium ion channel functionality in that when it is associated with an α 1 subunit and optionally a β subunit it enhances the density of current flow in the calcium ion channel thus created,

which method comprises the step of culturing the recombinant host cells of claim 11 or claim 12 under conditions wherein a recombinant protein is produced by the recombinant host cells.

14. A method to produce a functional recombinant calcium ion channel displayed on a cell which method comprises

(a) providing a cell that produces an α 1 subunit and that contains the recombinant nucleic acid molecule as set forth in claim 9 ; and

(b) culturing said cell under conditions wherein the nucleotide sequence of claim 9 is expressed,

thereby producing a functional recombinant calcium ion channel displayed on the cell.

15. Recombinant cells obtained in the method of claim 14 .

16. A method to identify a compound that is an agonist or antagonist of calcium ion channel activity which method comprises culturing the cells of claim 15 in with presence and absence of a candidate compound,

whereby an increase in calcium ion flow in the presence as opposed to the absence of said compound identifies said candidate compound as an agonist; and

whereby a decrease in the calcium ion flow in the presence as opposed to the absence of said channel identifies said compound as an antagonist.

17. A method to detect the production of mRNA encoding an α 2 δ protein, which method comprises contacting mRNA to be assessed for the presence of said α 2 δ encoding RNA with a probe which is the complement of SEQ ID NO:1, under conditions of high stringency which are defined as 50% formamide in Church buffer at +50° C. or 65° C. in aqueous buffer, and washed at high stringency conditions comprising 0.5×SSC, 0.1% SDS to 0.1×SSC, 0.1% SDS, 65° C. to 68° C.; whereby hybridization of said probe to said RNA under said conditions demonstrates the production of α 2 δ encoding RNA in said sample.

18. An isolated or recombinant nucleic acid comprising (a) a nucleotide sequence that hybridizes to DNA sequence complementary to SEQ ID NO:1, wherein the conditions of high stringency comprise 50% formamide in Church buffer at +50° C. or 65° C. in aqueous buffer, and washed at high stringency conditions comprising 0.5×SSC, 0.1% SDS to 0.1×SSC, 0.1% SDS, 65° C. to 68° C., and the nucleotide sequence encodes a protein which functions as an α 2 δ calcium channel subunit in that when it is associated with an α 1 subunit and optionally a β subunit it enhances the density of current flow in the calcium ion channel thus created; or, (b) a nucleotide sequence complementary to the full length sequence of (a).

19. The nucleic acid of claim 18 , further comprising a detectable label, wherein optionally the detectable label comprises a radioactive label, a biotin, a fluorescent probe or a chemiluminescent probe.

Assignments (4)
CHANGE OF NAME Recorded Sep 15, 2010
From: NEUROMED PHARMACEUTICALS LTD.
To: ZALICUS PHARMACEUTICALS LTD.
Reel/Frame 024990/0430 →
CHANGE OF NAME Recorded Aug 11, 2006
From: NEUROMED TECHNOLOGIES INC.
To: NEUROMED PHARMACEUTICALS LTD.
Reel/Frame 018099/0664 →
CORRECTION TO THE SPELLING OF THE THIRD ASSIGNOR, AND THE ASSIGNEE ADDRESS Recorded Dec 22, 2004
From: PARKER, DAVID; XU, XIANGHONG; KHAWAJA, AFSHEEN; MEZEYOVA, JANETTE; SNUTCH, TERRANCE P.
To: NEUROMED TECHNOLOGIES INC.
Reel/Frame 016136/0758 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 22, 2004
From: PARKER, DAVID; XU, XIANGHONG; KHWAJA, AFSHEEN; MEZEYOVA, JANETTE; SNUTCH, TERRANCE P.
To: NEUROMED TECHNOLOGIES INC.
Reel/Frame 015490/0956 →